From: Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma
Variables | No. patients | OS (%) | P a | χ2 | ||
---|---|---|---|---|---|---|
 |  | 1 y | 3 y | 5 y |  |  |
Ageb (y) | Â | Â | Â | Â | Â | Â |
   <60 | 41 | 65.9 | 19.5 | 17.1 | 0.555 | 0.348 |
   ≥60 | 44 | 63.6 | 25.0 | 20.5 |  |  |
Histological grade | Â | Â | Â | Â | Â | |
   Well | 34 | 66.7 | 25.0 | 25.0 | 0.996 | 0.008 |
   Moderately | 39 | 67.6 | 20.6 | 17.6 |  |  |
   Poorly | 12 | 61.5 | 23.1 | 17.9 |  |  |
SCCAc (ng/ml) | Â | Â | Â | Â | Â | |
   ≤ 1 | 43 | 69.8 | 18.6 | 16.2 | 0.200 | 1.639 |
   > 1 | 21 | 71.4 | 19.0 | 14.3 |  |  |
TSGFd (ng/ml) | Â | Â | Â | Â | Â | |
   ≤ 70 | 33 | 69.7 | 15.2 | 12.1 | 0.244 | 1.356 |
   > 70 | 22 | 68.2 | 22.7 | 18.2 |  |  |
T Stage | Â | Â | Â | Â | Â | Â |
   1~2 | 21 | 90.5 | 23.8 | 14.3 | 0.303 | 1.061 |
   3~4 | 64 | 56.3 | 25.0 | 20.3 |  |  |
Cervical lymph node metastasis | Â | Â | Â | Â | ||
   positive | 66 | 63.6 | 18.2 | 15.2 | 0.103 | 2.662 |
   negative | 19 | 68.4 | 36.8 | 31.6 |  |  |
TNM Stage | Â | Â | Â | Â | Â | Â |
   I~II | 7 | 100 | 28.5 | 28.5 | 0.678 | 0.173 |
   III~IV | 78 | 61.5 | 21.8 | 17.9 |  |  |
Oct4e | Â | Â | Â | Â | Â | |
   High Expression | 14 | 85.7 | 71.4 | 57.1 | 0.000 | 15.661 |
   Low Expression | 71 | 60.6 | 12.7 | 11.3 |  |  |
Sox2e | Â | Â | Â | Â | Â | Â |
   High Expression | 67 | 59.7 | 23.9 | 19.4 | 0.683 | 0.166 |
   Low Expression | 18 | 83.3 | 16.7 | 16.7 |  |  |
Oct4 & Sox2 | Â | Â | Â | 0.000 | 17.991 | |
   Both high | 13 | 88.2 | 76.9 | 61.5 |  |  |
   Either high | 55 | 54.5 | 10.9 | 9.1 |  |  |
   Both low | 17 | 82.4 | 17.6 | 17.6 |  |  |